Reference
HPRA. Teratogenicity of valproate-containing medicines (Epilim) - Reminder of important restrictions for use in women and girls. Drug Safety Newsletter : No. 97, May 2020. Available from: URL: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/hpra-drug-safety-newsletter-97th-edition.pdf?sfvrsn=5
Rights and permissions
About this article
Cite this article
Reminder of valproate-related teratogenicity. Reactions Weekly 1804, 5 (2020). https://doi.org/10.1007/s40278-020-78434-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-78434-3